Tdc Admet Benchmarking Group

The TDC ADMET Benchmarking Group focuses on the assessment of absorption, distribution, metabolism, excretion, and toxicity (ADMET) properties in small molecule drug discovery. It aims to optimize the drug development process through standardized benchmarking. The group is dedicated to establishing and maintaining high-quality datasets and evaluation standards to enhance the accuracy and reliability of models, thereby improving the clinical success rate of drug candidates and reducing development risks.